185 related articles for article (PubMed ID: 30322860)
1. UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells.
Mooneyham A; Iizuka Y; Yang Q; Coombes C; McClellan M; Shridhar V; Emmings E; Shetty M; Chen L; Ai T; Meints J; Lee MK; Gardner M; Bazzaro M
Mol Cancer Res; 2019 Feb; 17(2):370-383. PubMed ID: 30322860
[TBL] [Abstract][Full Text] [Related]
2. The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol.
Hoshino A; Clemente V; Shetty M; Castle B; Odde D; Bazzaro M
J Biol Chem; 2023 Nov; 299(11):105355. PubMed ID: 37858676
[TBL] [Abstract][Full Text] [Related]
3. UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs.
Habicht J; Mooneyham A; Shetty M; Zhang X; Shridhar V; Winterhoff B; Zhang Y; Cepela J; Starr T; Lou E; Bazzaro M
Cancer Biol Ther; 2019; 20(10):1304-1313. PubMed ID: 31328624
[TBL] [Abstract][Full Text] [Related]
4. The Microtubule Severing Protein UNC-45A Counteracts the Microtubule Straightening Effects of Taxol.
Hoshino A; Clemente V; Shetty M; Castle B; Odde D; Bazzaro M
bioRxiv; 2023 Sep; ():. PubMed ID: 37745537
[TBL] [Abstract][Full Text] [Related]
5. UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin II.
Habicht J; Mooneyham A; Hoshino A; Shetty M; Zhang X; Emmings E; Yang Q; Coombes C; Gardner MK; Bazzaro M
J Cell Sci; 2021 Jan; 134(1):. PubMed ID: 33262310
[TBL] [Abstract][Full Text] [Related]
6. UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.
Iizuka Y; Cichocki F; Sieben A; Sforza F; Karim R; Coughlin K; Isaksson Vogel R; Gavioli R; McCullar V; Lenvik T; Lee M; Miller J; Bazzaro M
J Immunol; 2015 Nov; 195(10):4760-70. PubMed ID: 26438524
[TBL] [Abstract][Full Text] [Related]
7. UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System.
Clemente V; Hoshino A; Meints J; Shetty M; Starr T; Lee M; Bazzaro M
Cells; 2021 Jun; 10(7):. PubMed ID: 34206743
[TBL] [Abstract][Full Text] [Related]
8. UNC-45A is required for neurite extension via controlling NMII activation.
Iizuka Y; Mooneyham A; Sieben A; Chen K; Maile M; Hellweg R; Schütz F; Teckle K; Starr T; Thayanithy V; Vogel RI; Lou E; Lee MK; Bazzaro M
Mol Biol Cell; 2017 May; 28(10):1337-1346. PubMed ID: 28356421
[TBL] [Abstract][Full Text] [Related]
9. UNC-45A: A potential therapeutic target for malignant tumors.
Wang H; Sun F
Heliyon; 2024 May; 10(10):e31276. PubMed ID: 38803956
[TBL] [Abstract][Full Text] [Related]
10. UNC-45a promotes myosin folding and stress fiber assembly.
Lehtimäki JI; Fenix AM; Kotila TM; Balistreri G; Paavolainen L; Varjosalo M; Burnette DT; Lappalainen P
J Cell Biol; 2017 Dec; 216(12):4053-4072. PubMed ID: 29055011
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
[No Abstract] [Full Text] [Related]
12. Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.
Yu Y; Gaillard S; Phillip JM; Huang TC; Pinto SM; Tessarollo NG; Zhang Z; Pandey A; Wirtz D; Ayhan A; Davidson B; Wang TL; Shih IeM
Cancer Cell; 2015 Jul; 28(1):82-96. PubMed ID: 26096845
[TBL] [Abstract][Full Text] [Related]
13. Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
Rodrigues-Ferreira S; Nehlig A; Moindjie H; Monchecourt C; Seiler C; Marangoni E; Chateau-Joubert S; Dujaric ME; Servant N; Asselain B; de Cremoux P; Lacroix-Triki M; Arnedos M; Pierga JY; André F; Nahmias C
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23691-23697. PubMed ID: 31685623
[TBL] [Abstract][Full Text] [Related]
14. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
[TBL] [Abstract][Full Text] [Related]
15. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
Jiang L; Siu MK; Wong OG; Tam KF; Lu X; Lam EW; Ngan HY; Le XF; Wong ES; Monteiro LJ; Chan HY; Cheung AN
Clin Cancer Res; 2011 Nov; 17(21):6924-33. PubMed ID: 21926165
[TBL] [Abstract][Full Text] [Related]
16. A myosin chaperone, UNC-45A, is a novel regulator of intestinal epithelial barrier integrity and repair.
Lechuga S; Cartagena-Rivera AX; Khan A; Crawford BI; Narayanan V; Conway DE; Lehtimäki J; Lappalainen P; Rieder F; Longworth MS; Ivanov AI
FASEB J; 2022 May; 36(5):e22290. PubMed ID: 35344227
[TBL] [Abstract][Full Text] [Related]
17. Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.
Poruchynsky MS; Giannakakou P; Ward Y; Bulinski JC; Telford WG; Robey RW; Fojo T
Biochem Pharmacol; 2001 Dec; 62(11):1469-80. PubMed ID: 11728383
[TBL] [Abstract][Full Text] [Related]
18. Furry promotes acetylation of microtubules in the mitotic spindle by inhibition of SIRT2 tubulin deacetylase.
Nagai T; Ikeda M; Chiba S; Kanno S; Mizuno K
J Cell Sci; 2013 Oct; 126(Pt 19):4369-80. PubMed ID: 23886946
[TBL] [Abstract][Full Text] [Related]
19. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
George JA; Chen T; Taylor CC
Cancer Res; 2005 Nov; 65(22):10381-8. PubMed ID: 16288028
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
